Contract 36E79721D0051
Xlcare Pharmaceuticals Inc · Department Of Veterans Affairs · September 14, 2021
Xlcare Pharmaceuticals Inc was awarded a federal contract by Department Of Veterans Affairs on September 14, 2021 for an undisclosed amount of work in pharmaceutical preparation manufacturing. It was awarded under full and open competition. The contract has been modified 1 time since the base award It uses firm fixed-price contract pricing. The most recent modification was on October 9, 2025. If all options are exercised, the contract could reach $1.42 million.
Contract details
- PIID
- 36E79721D0051
- Award type
- —
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- Drugs And Biologicals
- First action
- September 14, 2021
- Latest action
- October 9, 2025
Description
EXERCISE THE FOURTH OPTION YEAR FOR DUTASTERIDE CAPSULES CONTRACT 36E79721D0051 WITH XLCARE PHARMACEUTICALS INC. WITH NO PRICE CHANGES
Modification timeline
-
October 9, 2025Mod P00006 · Exercise An Option$0
-
September 14, 2021Base award2 LINE ITEMS DUTASTERIDE CAPSULES. AWARDED FOR A BASE YEAR OF 12/23/2021 TO 12/22/2022 PLUS 4 ONE-YEAR OPTION PERIODS.$0
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Petnet Solutions, Inc. | Department Of Veterans Affairs | April 1, 2026 | $387.4K |
| Eli Lilly And Company | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Exelan Pharmaceuticals Inc | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Cardinal Health 414, Llc | Department Of Veterans Affairs | April 1, 2026 | $122.9K |
| Guardian Pharmacy Of Indianapolis Nuclear, Llc | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Jubilant Draximage Inc | Department Of Veterans Affairs | April 1, 2026 | $0 |
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 1,187 | $4.96B |
| 2 | Merck Sharp & Dohme Llc | 26 | $894.71M |
| 3 | Sanofi Vaccines Us Inc. | 57 | $702.38M |
| 4 | Pfizer Inc | 169 | $541.15M |
| 5 | Glaxosmithkline, Llc | 14 | $505.04M |
| 6 | Phlow Corp. | 1 | $105.27M |
| 7 | Exelan Pharmaceuticals Inc | 76 | $104.30M |
| 8 | Seqirus USA Inc | 47 | $59.15M |
| 9 | Emergent Biosolutions Canada Inc | 2 | $53.73M |
| 10 | Mckesson Specialty Distribution Llc | 1 | $51.05M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 36E79721D0051?
Contract 36E79721D0051 is a federal contract awarded to Xlcare Pharmaceuticals Inc by Department Of Veterans Affairs on September 14, 2021 for an undisclosed amount of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 1 time since the base award.
Who won contract 36E79721D0051?
Xlcare Pharmaceuticals Inc won contract 36E79721D0051 from Department Of Veterans Affairs.
How much is contract 36E79721D0051 worth?
Contract 36E79721D0051 has obligated $0 to date but carries a potential ceiling of $1.42 million if fully funded and all options are exercised.